Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Original Article from The New England Journal of Medicine - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
October 20, 2018
|
| In: |
The New England journal of medicine
Year: 2018, Jahrgang: 379, Pages: 2108-2121 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1809615 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1809615 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1809615 |
| Verfasserangaben: | Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero, Stephen Y. Chui, Roel Funke, Amreen Husain, Eric P. Winer, Sherene Loi, and Leisha A. Emens, for the IMpassion130 Trial Investigators |
| Zusammenfassung: | Original Article from The New England Journal of Medicine - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer |
|---|---|
| Beschreibung: | This article was published on October 20, 2018, and updated on November 15, 2018, at NEJM.org Gesehen am 21.04.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1809615 |